A recently developed typhoid Vi polysaccharide vaccine: rationale and clinical profile.
Zuckerman
J N
JN
Academic Centre for Travel Medicine and Vaccines, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, England. j.zuckerman@rfc.ucl.ac.uk
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D018432:Drug Resistance, Multiple; D006801:Humans; D015994:Incidence; D011135:Polysaccharides, Bacterial; D014195:Travel; D014435:Typhoid Fever / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D014436:Typhoid-Paratyphoid Vaccines
D000900:Anti-Bacterial Agents; D011135:Polysaccharides, Bacterial; D014436:Typhoid-Paratyphoid Vaccines; C057664:Vi polysaccharide vaccine, typhoid